Pharmaceuticals - San Diego, California, United States
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
Woo Commerce
Facebook Widget
Cloudflare DNS
Google Tag Manager
Google Font API
CloudFlare Hosting